Market Cap ₹252 Cr.
Stock P/E 0.0
P/B -29.6
Current Price ₹190
Book Value ₹ -6.4
Face Value 10
52W High ₹191
Dividend Yield 0%
52W Low ₹ 6.9
Jhandewalas Foods Ltd is an India-based company engaged in manufacturing ghee. The Company also manufactures mangodi on job work basis and additionally markets Poha, Saffron and Dalia. It offers its merchandise beneath the brand names Naman's and Godhenu. It operates a production unit located at Jaipur, Rajasthan. Its products consist of Naman desi ghee, Godhenu cow ghee, Naman gold ghee, Naman's kesar and Naman Daliya. Naman Daliya is multigrain daliya and it offers it in 200 gm pack, each in sweet and savory taste. It offer Naman's kesar in one gm pack. It provides Mangodi in 200 gm pack. It provides Naman gold gee in a liter pack (tin), Godhenu cow ghee is in 1 liter pack and 15 liters pack in tin and jar pack. Naman desi ghee is in 200 ml 500 ml, one liter, 5 liters, and 15 liters pack.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 115 | 151 | 140 | 143 | 149 | 178 | 155 | 48 | 28 | 32 | 13 | |
Other Income | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 6 | |
Total Income | 116 | 152 | 142 | 143 | 149 | 178 | 155 | 50 | 28 | 32 | 19 | |
Total Expenditure | 113 | 147 | 136 | 137 | 140 | 168 | 167 | 70 | 46 | 37 | 16 | |
Operating Profit | 3 | 5 | 6 | 6 | 9 | 10 | -12 | -20 | -18 | -6 | 3 | |
Interest | 2 | 3 | 3 | 4 | 5 | 5 | 6 | 3 | 1 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |
Exceptional Income / Expenses | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | -3 | |
Profit Before Tax | 1 | 2 | 2 | 2 | 4 | 5 | -18 | -24 | -19 | -4 | -0 | |
Provision for Tax | 1 | 1 | 1 | 1 | 1 | 2 | -2 | 0 | 0 | 0 | 0 | |
Profit After Tax | 1 | 1 | 2 | 1 | 2 | 3 | -16 | -24 | -19 | -4 | -0 | |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 1 | 1 | 2 | 1 | 2 | 3 | -16 | -24 | -19 | -4 | -0 | |
Adjusted Earnings Per Share | 1 | 1.6 | 2.4 | 1.3 | 3.1 | 3.1 | -15.5 | -23.1 | -18.1 | -4 | -0.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -59% | -35% | -41% | -20% |
Operating Profit CAGR | 0% | 0% | -21% | 0% |
PAT CAGR | 0% | 0% | -100% | -100% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 2801% | 180% | 56% | NA% |
ROE Average | 0% | 0% | -112% | -43% |
ROCE Average | 1% | -27% | -26% | -3% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 7 | 8 | 10 | 11 | 13 | 33 | 17 | -7 | -26 | -30 | -30 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 3 | 3 | 3 | 5 | 5 | 10 | 8 | 4 | 4 | 2 | 2 |
Other Non-Current Liabilities | 0 | 1 | 1 | 4 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
Total Current Liabilities | 18 | 27 | 35 | 38 | 41 | 47 | 60 | 61 | 56 | 55 | 46 |
Total Liabilities | 28 | 39 | 49 | 58 | 61 | 90 | 86 | 58 | 35 | 27 | 18 |
Fixed Assets | 5 | 5 | 4 | 4 | 4 | 4 | 4 | 16 | 16 | 16 | 10 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 |
Total Current Assets | 24 | 34 | 44 | 54 | 57 | 86 | 81 | 43 | 18 | 11 | 8 |
Total Assets | 28 | 39 | 49 | 58 | 61 | 90 | 86 | 58 | 35 | 27 | 18 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 0 | 1 | 1 | 1 | 0 | 2 | 2 | 1 | 0 | 1 |
Cash Flow from Operating Activities | 1 | 4 | 1 | -1 | 5 | -20 | 0 | 25 | 1 | 4 | 2 |
Cash Flow from Investing Activities | -1 | -1 | 2 | -0 | -3 | -2 | -1 | -11 | -1 | -1 | 6 |
Cash Flow from Financing Activities | -0 | -3 | -3 | 2 | -3 | 23 | 1 | -15 | -1 | -3 | -8 |
Net Cash Inflow / Outflow | -0 | 1 | -0 | 1 | -1 | 1 | 0 | -1 | -0 | 0 | -0 |
Closing Cash & Cash Equivalent | 0 | 1 | 1 | 2 | 0 | 2 | 2 | 1 | 0 | 1 | 0 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 1.05 | 1.57 | 2.4 | 1.27 | 3.07 | 3.09 | -15.47 | -23.13 | -18.09 | -3.99 | -0.09 |
CEPS(Rs) | 1.31 | 1.9 | 2.93 | 1.8 | 3.6 | 3.47 | -14.97 | -22.58 | -17.61 | -3.57 | 0.23 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.8 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 9.58 | 11.15 | 13.56 | 14.83 | 18.19 | 31.72 | 16.25 | -6.88 | -24.97 | -28.96 | -29.05 |
Core EBITDA Margin(%) | 2.11 | 2.63 | 3.11 | 4.02 | 5.92 | 5.82 | -7.54 | -46.09 | -60.04 | -16.82 | -24.15 |
EBIT Margin(%) | 2.93 | 2.88 | 3.9 | 3.8 | 5.71 | 5.65 | -7.81 | -42.97 | -61.66 | -12.12 | 0.95 |
Pre Tax Margin(%) | 1.13 | 1.19 | 1.63 | 1.06 | 2.46 | 2.86 | -11.55 | -49.34 | -63.56 | -12.31 | -0.7 |
PAT Margin (%) | 0.67 | 0.76 | 1.26 | 0.66 | 1.52 | 1.78 | -10.22 | -49.34 | -63.56 | -12.31 | -0.7 |
Cash Profit Margin (%) | 0.83 | 0.92 | 1.54 | 0.93 | 1.78 | 2 | -9.89 | -48.16 | -61.85 | -11.01 | 1.83 |
ROA(%) | 2.72 | 3.43 | 4.03 | 1.76 | 3.79 | 4.19 | -18.05 | -32.93 | -39.87 | -13.2 | -0.4 |
ROE(%) | 10.93 | 15.17 | 19.45 | 8.98 | 18.62 | 13.8 | -64.48 | -493.41 | 0 | 0 | 0 |
ROCE(%) | 17.03 | 16.81 | 15.54 | 12.99 | 18 | 15.46 | -15.71 | -36.33 | -58.5 | -23 | 1.25 |
Receivable days | 54.72 | 47.3 | 58.41 | 68.58 | 75.48 | 78.76 | 113.69 | 296.69 | 242.8 | 103.95 | 146.4 |
Inventory Days | 17.59 | 18.37 | 37.84 | 51.24 | 55.47 | 61.82 | 71.43 | 138.17 | 101.35 | 30.38 | 48.8 |
Payable days | 25.24 | 16.93 | 20.76 | 23.38 | 21.21 | 15.55 | 19.56 | 81.4 | 161.42 | 120.33 | 311.44 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 12.71 | 0 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 1.24 | 1.53 | -0.81 | -0.35 | -0.26 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 176.58 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.12 | 0.16 | 0.22 | 0.25 | 0.26 | 0.49 | 0.52 | 1.1 | 1.97 | 1.6 | 3.55 |
EV/Core EBITDA(x) | 4.31 | 5.2 | 5.19 | 6.19 | 4.32 | 8.35 | -6.91 | -2.61 | -3.17 | -9.22 | 14.17 |
Net Sales Growth(%) | 0 | 31.47 | -7.58 | 1.94 | 4.15 | 19.71 | -12.92 | -69.2 | -40.87 | 12.25 | -59.33 |
EBIT Growth(%) | 0 | 29.17 | 25.15 | -0.54 | 56.5 | 18.44 | -220.62 | -70.3 | 12.85 | 77.62 | 103.09 |
PAT Growth(%) | 0 | 50.11 | 52.83 | -46.94 | 141.16 | 40.17 | -601.04 | -49.54 | 21.77 | 77.95 | 97.77 |
EPS Growth(%) | 0 | 50.11 | 52.83 | -46.94 | 141.15 | 0.41 | -601.04 | -49.54 | 21.77 | 77.95 | 97.77 |
Debt/Equity(x) | 1.82 | 2.91 | 2.83 | 3.17 | 2.66 | 1.49 | 3.4 | -6.73 | -1.83 | -1.47 | -1.2 |
Current Ratio(x) | 1.34 | 1.25 | 1.26 | 1.43 | 1.38 | 1.82 | 1.33 | 0.7 | 0.33 | 0.2 | 0.18 |
Quick Ratio(x) | 1.03 | 0.89 | 0.71 | 0.88 | 0.78 | 1.06 | 0.92 | 0.51 | 0.25 | 0.19 | 0.12 |
Interest Cover(x) | 1.62 | 1.71 | 1.72 | 1.39 | 1.76 | 2.02 | -2.09 | -6.75 | -32.47 | -62.88 | 0.58 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 1.21 | 2.22 | 8.34 | 5.24 | 5.56 | 0 |
# | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 71.63 | 71.63 | 71.63 | 71.63 | 65.78 | 65.78 | 65.78 | 65.78 | 65.78 | 65.78 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 28.37 | 28.37 | 28.37 | 28.37 | 34.22 | 34.22 | 34.22 | 34.22 | 34.22 | 34.22 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.73 | 0.73 | 0.73 | 0.73 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 | 0.67 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.29 | 0.29 | 0.29 | 0.29 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 | 1.03 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About